专利检索 ap:("VIIV HEALTHCARE UK (NO.5) LIMITED") AND inv:"Eric P. Gillis" 第 1 页

1.

发明授权
Inhibitors of human immunodeficiency virus replication 有权

公开(公告)号：US11541055B2

公开(公告)日：2023-01-03

申请号：US16762209

申请日：2019-10-22

申请人： ViiV Healthcare UK (No. 5) LIMITED

发明人： Eric P. Gillis , Kyle E. Parcella , Manoj Patel

IPC分类号： A61K31/517 , A61K31/496 , A61K31/4985 , A61K31/5365 , A61K9/00 , C07D403/14 , A61K31/7068

摘要： Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

2.

发明授权
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication 有权

公开(公告)号：US11505543B2

公开(公告)日：2022-11-22

申请号：US17042413

申请日：2019-04-11

申请人： VIIV HEALTHCARE UK (NO.5) LIMITED

发明人： Makonen Belema , John A. Bender , David B. Frennesson , Eric P. Gillis , Christiana Iwuagwu , John F. Kadow , B. Narasimhulu Naidu , Kyle E. Parcella , Kevin M. Peese , Ramkumar Rajamani , Mark G. Saulnier , Alan Xiangdong Wang , Manoj Patel , Michael S. Bowsher

IPC分类号： C07D401/14 , C07D403/14 , C07D405/14 , A61K31/517 , A61P31/18 , C07D403/12 , C07D413/14 , C07D491/052

摘要： Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

3.

发明授权
Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication 有权

公开(公告)号：US12129255B2

公开(公告)日：2024-10-29

申请号：US17268107

申请日：2020-06-17

申请人： VIIV HEALTHCARE UK (No. 5) LIMITED

发明人： Eric P. Gillis , Christiana Iwuagwu

IPC分类号： C07D487/04 , A61K9/00 , A61K45/06 , A61P31/18

CPC分类号： C07D487/04 , A61K9/0019 , A61K9/0053 , A61K45/06 , A61P31/18

摘要： The compound

and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.